13F

Stock

Dyne Therapeutics, Inc.

DYN · held by 2 managers

Reported value

$3.11M

Holders

2

+1 new · −0 exited

Holders’ est. mark

$1.27M

Price effect on 1 books still in the name

Largest holder

$2.38M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC84K$2.38M$1.27MAdded$344.4K
Marex Group plc25.5K$723.9KNew

Positions as of Q1 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.